Literature DB >> 17601907

Recurrence of ischemic placental disease.

Cande V Ananth1, Morgan R Peltier, Martin R Chavez, Russell S Kirby, Darios Getahun, Anthony M Vintzileos.   

Abstract

OBJECTIVE: To test the hypothesis that the presence of preeclampsia, small for gestational age (SGA)-birth, and placental abruption in the first pregnancy confers increased risk in the second pregnancy.
METHODS: A retrospective cohort study entailing a case-crossover analysis was performed based on women who had two consecutive singleton live births (n=154,810) between 1989 and 1997 in Missouri. Small for gestational age was defined as infants with birth weight below the 10th centile for gestational age. Risk and recurrence of ischemic placental disease was assessed from fitting logistic regression models after adjusting for several confounders.
RESULTS: Preeclampsia in the first pregnancy was associated with significantly increased risk of preeclampsia (odds ratio 7.03, 95% confidence interval 6.51, 7.59), SGA (odds ratio 1.16, 95% confidence interval 1.06, 1.27), and placental abruption (odds ratio 1.90, 95% confidence interval 1.51, 2.38) in the second pregnancy. Similarly, women with SGA and abruption in the first pregnancy were associated with increased risks of all other conditions in the second pregnancy.
CONCLUSION: Women with preeclampsia, SGA, and placental abruption in their first pregnancy--conditions that constitute ischemic placental disease--are at substantially increased risk of recurrence of any or all these conditions in their second pregnancy. Although causes of these conditions remain largely speculative, these entities may manifest through a common pathway of ischemic placental disease with significant risk of recurrence.

Entities:  

Mesh:

Year:  2007        PMID: 17601907     DOI: 10.1097/01.AOG.0000266983.77458.71

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  47 in total

1.  Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial.

Authors:  Ida Martinelli; Piero Ruggenenti; Irene Cetin; Giorgio Pardi; Annalisa Perna; Patrizia Vergani; Barbara Acaia; Fabio Facchinetti; Giovanni Battista La Sala; Maddalena Bozzo; Stefania Rampello; Luca Marozio; Olimpia Diadei; Giulia Gherardi; Sergio Carminati; Giuseppe Remuzzi; Pier Mannuccio Mannucci
Journal:  Blood       Date:  2012-01-30       Impact factor: 22.113

2.  Genome-wide and candidate gene association studies of placental abruption.

Authors:  Tsegaselassie Workalemahu; Daniel A Enquobahrie; Amy Moore; Sixto E Sanchez; Cande V Ananth; Percy N Pacora; Liming Liang; Manuel Salazar; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

Review 3.  Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.

Authors:  Roberto Romero; Offer Erez; Maik Hüttemann; Eli Maymon; Bogdan Panaitescu; Agustin Conde-Agudelo; Percy Pacora; Bo Hyun Yoon; Lawrence I Grossman
Journal:  Am J Obstet Gynecol       Date:  2017-06-12       Impact factor: 8.661

Review 4.  The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.

Authors:  Frederick Schatz; Ozlem Guzeloglu-Kayisli; Sefa Arlier; Umit A Kayisli; Charles J Lockwood
Journal:  Hum Reprod Update       Date:  2016-02-23       Impact factor: 15.610

Review 5.  Maternal, Labor, Delivery, and Perinatal Outcomes Associated with Placental Abruption: A Systematic Review.

Authors:  Katheryne L Downes; Katherine L Grantz; Edmond D Shenassa
Journal:  Am J Perinatol       Date:  2017-03-22       Impact factor: 1.862

6.  A genome-wide association study of variations in maternal cardiometabolic genes and risk of placental abruption.

Authors:  Amy Moore; Daniel A Enquobahrie; Sixto E Sanchez; Cande V Ananth; Percy N Pacora; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

7.  Abruptio placentae risk and genetic variations in mitochondrial biogenesis and oxidative phosphorylation: replication of a candidate gene association study.

Authors:  Tsegaselassie Workalemahu; Daniel A Enquobahrie; Bizu Gelaye; Timothy A Thornton; Fasil Tekola-Ayele; Sixto E Sanchez; Pedro J Garcia; Henry G Palomino; Anjum Hajat; Roberto Romero; Cande V Ananth; Michelle A Williams
Journal:  Am J Obstet Gynecol       Date:  2018-09-05       Impact factor: 8.661

8.  Placental abruption and subsequent risk of pre-eclampsia: a population-based case-control study.

Authors:  Samantha E Parker; Martha M Werler; Mika Gissler; Minna Tikkanen; Cande V Ananth
Journal:  Paediatr Perinat Epidemiol       Date:  2015-03-11       Impact factor: 3.980

9.  Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality.

Authors:  Cande V Ananth; Olga Basso
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

10.  Risk of Ischemic Placental Disease in Relation to Family History of Preeclampsia.

Authors:  Cande V Ananth; Kathleen Jablonski; Leslie Myatt; James M Roberts; Alan T N Tita; Kenneth J Leveno; Uma M Reddy; Michael W Varner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Marshall W Carpenter; Philip Samuels; Anthony Sciscione; Jorge E Tolosa; George Saade; Yoram Sorokin
Journal:  Am J Perinatol       Date:  2018-10-03       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.